GLOBAL Exponential Technologies
Private Company
Funding information not available
Overview
Founded in 2018, Global Exponential Technologies (GxT) is a private, San Francisco-based company providing AI-augmented software solutions for regulatory and quality processes in the medical device and biopharma sectors. Its core products, RegWriter™ and SmartComplaints™, automate critical documentation and complaint categorization to improve efficiency and compliance. The company operates on a B2B software model, targeting life science organizations with tools designed to reduce manual effort and human error in the highly regulated submission and post-market surveillance landscape.
Technology Platform
AI and machine learning platform tailored for life science regulatory processes, featuring a 'human-in-the-loop' approach to automate authoring (e.g., CTD Module 3) and classification (e.g., IMDRF complaint codes).
Opportunities
Risk Factors
Competitive Landscape
GxT competes in the regulatory software space against large platforms like Veeva Vault RIM and Dassault Systèmes' Medidata, as well as other niche AI startups. Its differentiation lies in its specific focus on AI-augmented authoring and classification for quality and post-market processes, combined with deep domain expertise.